-
| Sector | Healthcare |
|---|---|
| Industry | Medical Care Facilities |
| Exchange | LSE |
| CurrencyCode | GBP |
| ISIN | GB00BYQCS703 |
| Beta | 2.81 |
|---|---|
| Market Cap | 1M |
| PE Ratio | None |
| Target Price | None |
| Dividend Yield | None |
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments. The company offers The GP Service, an online telehealth platform, that provides patients with video consultations, online prescriptions, and primary care services; and operates Treat It, an online clinic focused on management of chronic pain. It also provides cultivation consultancy for cannabis businesses, as well as develops and distributes cannabis derived medicinal and wellness products. Kanabo Group Plc was incorporated in 2016 and is based in London, the United Kingdom.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for KNB.LSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025